An avian flu H5N1 detection test has been launched from bioMérieux.

In line with its historical commitment to the fight against infectious diseases and with extensive experience in the field of emerging respiratory pathogens, bioMérieux has made available an avian Influenza H5N1 detection test.

Developed to respond to the needs of reference laboratories involved in the identification of the disease and in the fight against avian flu, the test, called NucliSens EasyQ® Influenza H5 and N1 is a kit of reagents exclusively for research purposes. It can detect the presence of both the H5 and N1 genetic targets in 90 minutes and will be used with the bioMérieux’s NucliSens® range of molecular biology systems.

In the field of molecular biology, bioMérieux offers a full range of products from extraction to amplification and identification of genetic targets.